Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
7.06
+0.11 (1.66%)
At close: Jul 8, 2026, 4:00 PM EDT
6.89
-0.17 (-2.34%)
After-hours: Jul 8, 2026, 7:47 PM EDT
Evolus Market Cap
Evolus has a market cap or net worth of $447.15 million as of July 8, 2026. Its market cap has decreased by -25.26% in one year.
Market Cap
447.15M
Enterprise Value
562.26M
1-Year Change
-25.26%
Ranking
Category
Stock Price
$7.06
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from $271.30M to $447.15M, an increase of 64.82%. That is a compound annual growth rate of 6.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 457.00M | 6.01% |
| Dec 31, 2025 | 431.10M | -38.34% |
| Dec 31, 2024 | 699.10M | 16.17% |
| Dec 29, 2023 | 601.80M | 42.47% |
| Dec 30, 2022 | 422.40M | 16.75% |
| Dec 31, 2021 | 361.80M | 219.05% |
| Dec 31, 2020 | 113.40M | -66.03% |
| Dec 31, 2019 | 333.80M | 2.83% |
| Dec 31, 2018 | 324.60M | 19.65% |
| Feb 8, 2018 | 271.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Esperion Therapeutics | 815.60M |
| Ironwood Pharmaceuticals | 785.21M |
| Aquestive Therapeutics | 531.91M |
| Tilray Brands | 521.27M |
| Emergent BioSolutions | 422.06M |
| Kamada | 417.84M |
| Canopy Growth | 404.59M |
| Akebia Therapeutics | 380.93M |